Cecchini M, Cleary JM, Shyr Y, Chao J, et al. NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma. Br J Cancer 2024;130:476-482.
PMID: 38135713